We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medical device incubator and technology brokerage firm, Hatch Medical, announced
it has signed an exclusive, worldwide license agreement with physician inventor,
J. Kevin McGraw for his patent-pending percutaneous spinal stabilization system.
Cellectricon, a Swedish biotechnology company and a leading provider of cell-based
assays, announced that Scientifica will distribute the Dynaflow System for ion
channel drug discovery in the UK.
AcroMetrix announced that it has signed an agreement with Ambion Diagnostics,
a division of Ambion, to manufacture Armored RNA-based products and distribute
them to in vitro diagnostic laboratories and manufacturers.
BioMérieux announced it has received FDA approval for commercial sales
and marketing of the VITEK 2 Compact, an automated bacterial identification
and antibiotic susceptibility testing system.
The Yediot Ahronot Hebrew daily reports that negotiations to settle the
bitter dispute between Israel stent manufacturer Medinol, owned by Kobi and
Judith Richter, and U.S. company Boston Scientific, Medinol's former partner,
have reached an advanced stage.
Pearsalls, a UK-based medical device company, announced the early clinical results
of its novel artificial cervical disc implanted in nine patients at the Royal
Orthopaedic Hospital in Birmingham, England.
The FDA gave clearance to medical device manufacturer Suros Surgical Systems
to provide partial or complete removal of breast tissue with the ATEC breast
biopsy system.
Immunicon announced that the CellTracks Analyzer II was cleared by the FDA for
in vitro diagnostic (IVD) use through the 510(k) premarket notification process.
Thoratec said that the first patients have been enrolled in the destination
therapy and bridge-to-transplantation arms of the Phase II pivotal trial for
its HeartMate II LVAS (left ventricular assist system) device.